MicroSPECT/CT imaging of co-expressed HER2 and EGFR on subcutaneous human tumor xenografts in athymic mice using 111In-labeled bispecific radioimmunoconjugates

Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer

José Baselga, Javier Cortés, Sung‐Bae Kim et al. · New England Journal of Medicine · 2011 · 2.5K citations · Full text

Medicine, Oncology, Pharmacology +12

Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions.

Ronit Pinkas‐Kramarski, Lior Soussan, Hayley R. Waterman et al. · The EMBO Journal · 1996 · 770 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +14

Amplified and rearranged epidermal growth factor receptor genes in human glioblastomas reveal deletions of sequences encoding portions of the N- and/or C-terminal tails.

A. Jonas Ekstrand, Noriaki Sugawa, C. David James et al. · Proceedings of the National Academy of Sciences · 1992 · 607 citations

Medicine, Molecular Genetics, Oncology +10

Biochemical and Clinical Implications of the ErbB/HER Signaling Network of Growth Factor Receptors

Leah N. Klapper, Mark Kirschbaum, Michael Seta et al. · Advances in cancer research · 1999 · 546 citations

Life Sciences, Biochemistry, Molecular Biology +16

Human Breast Cancer Cells Selected for Resistance to Trastuzumab <i>In vivo</i> Overexpress Epidermal Growth Factor Receptor and ErbB Ligands and Remain Dependent on the ErbB Receptor Network

Christoph A. Ritter, Marianela Pérez-Torres, Cammie Rinehart et al. · Clinical Cancer Research · 2007 · 506 citations · Full text

Medicine, Oncology, Pharmacology +13